- Home
- SDRL vs CLDX Comparison
SDRL vs CLDX Comparison
Compare SDRL & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SDRL | CLDX |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.0B |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | SDRL | CLDX |
|---|---|---|
| Price | $41.25 | $28.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 15 |
| Target Price | $54.00 | ★ $63.07 |
| AVG Volume (30 Days) | 721.4K | ★ 1.1M |
| Earning Date | 11-03-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,437,000,000.00 | $12,743,000.00 |
| Revenue This Year | $13.63 | $19.74 |
| Revenue Next Year | $8.49 | $373.52 |
| P/E Ratio | $120.33 | ★ N/A |
| Revenue Growth | 3.75 | ★ 87.78 |
| 52 Week Low | $28.10 | $22.10 |
| 52 Week High | $55.47 | $45.14 |
Technical Indicators
Market Signals| Indicator | SDRL | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 36.08 | 45.96 |
| Support Level | $41.85 | $28.34 |
| Resistance Level | $45.50 | $31.47 |
| Average True Range (ATR) | 2.62 | 1.35 |
| MACD | -0.58 | 0.35 |
| Stochastic Oscillator | 2.59 | 71.35 |
Price Performance
Historical ComparisonAbout SDRL Seadrill Limited
Seadrill Ltd is an offshore drilling contractor company. The company is engaged in providing offshore drilling services to the oil and gas industry. The primary business of the company is the ownership and operation of drillships, semi-submersible rigs, and jack-up rigs for operations in shallow to ultra-deepwater areas in both benign and harsh environments. The geographical segments of the company are the United States, Brazil, Angola, Norway, and others. The company derives maximum revenue from Brazil.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.